These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26846865)

  • 21. Reversing stroke in the 2010s: lessons from Desmoteplase In Acute ischemic Stroke-2 (DIAS-2).
    Liebeskind DS
    Stroke; 2009 Sep; 40(9):3156-8. PubMed ID: 19608990
    [No Abstract]   [Full Text] [Related]  

  • 22. Refinement of the magnetic resonance diffusion-perfusion mismatch concept for thrombolytic patient selection: insights from the desmoteplase in acute stroke trials.
    Warach S; Al-Rawi Y; Furlan AJ; Fiebach JB; Wintermark M; Lindstén A; Smyej J; Bharucha DB; Pedraza S; Rowley HA
    Stroke; 2012 Sep; 43(9):2313-8. PubMed ID: 22738918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Can the target group for thrombolysis in acute ischemic stroke be widened? Current indication is very narrow--new study results are necessary].
    Murray V
    Lakartidningen; 2011 Jan 12-18; 108(1-2):16-7. PubMed ID: 21365808
    [No Abstract]   [Full Text] [Related]  

  • 24. Intra-arterial Therapy in the Early Treatment of Acute Ischaemic Stroke.
    Kappelle LJ; de Borst GJ
    Eur J Vasc Endovasc Surg; 2016 Jan; 51(1):1-2. PubMed ID: 26363971
    [No Abstract]   [Full Text] [Related]  

  • 25. Thrombolysis in acute stroke.
    del Zoppo GJ
    Neurologia; 1995 Dec; 10 Suppl 2():37-47. PubMed ID: 8714449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bridging therapy in acute ischemic stroke: are we ready for a new standard of care?
    Mazighi M; Labreuche J
    Stroke; 2011 Apr; 42(4):880-1. PubMed ID: 21372303
    [No Abstract]   [Full Text] [Related]  

  • 27. Preclusion of ischemic stroke patients from intravenous tissue plasminogen activator treatment for mild symptoms should not be based on low National Institutes of Health Stroke Scale Scores.
    Wendt M; Tütüncü S; Fiebach JB; Scheitz JF; Audebert HJ; Nolte CH
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):550-3. PubMed ID: 23433783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aphasia predicts unfavorable outcome in mild ischemic stroke patients and prompts thrombolytic treatment.
    Nesi M; Lucente G; Nencini P; Fancellu L; Inzitari D
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):204-8. PubMed ID: 23352114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of Early Arterial Recanalization and Tissue Fate in the Selection of Patients With the Greatest Potential to Benefit From Intravenous Tissue-Type Plasminogen Activator.
    Leiva-Salinas C; Patrie JT; Xin W; Michel P; Jovin T; Wintermark M
    Stroke; 2016 Feb; 47(2):397-403. PubMed ID: 26696647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local intra-arterial thrombolysis with urokinase for acute ischemic stroke before and after the approval of intravenous tissue plasminogen activator treatment in Taiwan.
    Yang FC; Lin CC; Hsueh CJ; Lee JT; Hsu CH; Lee KW; Peng GS
    Ann Vasc Surg; 2010 Nov; 24(8):1117-24. PubMed ID: 21035704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics and outcome of patients with early complete neurological recovery after thrombolysis for acute ischemic stroke.
    Blinzler C; Breuer L; Huttner HB; Schellinger PD; Schwab S; Köhrmann M
    Cerebrovasc Dis; 2011; 31(2):185-90. PubMed ID: 21160181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An unusual cause of ischemic stroke with successful thrombolysis.
    Corrado G; Panisi P; Checcarelli N; Ambrosiani L
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e691-2. PubMed ID: 24008132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient ischemic attack after tissue plasminogen activator: aborted stroke or unnecessary stroke therapy?
    Uchino K; Massaro L; Hammer MD
    Cerebrovasc Dis; 2010; 29(1):57-61. PubMed ID: 19893313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombolysis 3 to 4.5 hours after acute ischemic stroke.
    Fitzpatrick AE; Noone I; O'Shea DD
    N Engl J Med; 2008 Dec; 359(26):2840; author reply 2841. PubMed ID: 19115491
    [No Abstract]   [Full Text] [Related]  

  • 35. Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke.
    Prabhakaran S; Rivolta J; Vieira JR; Rincon F; Stillman J; Marshall RS; Chong JY
    Arch Neurol; 2010 May; 67(5):559-63. PubMed ID: 20212195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atrial fibrillation as an independent predictor for no early recanalization after IV-t-PA in acute ischemic stroke.
    Kimura K; Iguchi Y; Yamashita S; Shibazaki K; Kobayashi K; Inoue T
    J Neurol Sci; 2008 Apr; 267(1-2):57-61. PubMed ID: 17964602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Intravenous thrombolytic therapy of patients with acute cerebral infarction].
    Thomassen L; Sandset PM; Joakimsen O; Indredavik B; Russell D
    Tidsskr Nor Laegeforen; 2003 Mar; 123(5):638-9. PubMed ID: 12683192
    [No Abstract]   [Full Text] [Related]  

  • 38. Neuroradiologists intervene with new therapy for stroke.
    Sandrick K
    Diagn Imaging (San Franc); 1999 Jan; 21(1):19-20. PubMed ID: 11692376
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of tissue plasminogen activator in acute ischemic stroke.
    Hatcher MA; Starr JA
    Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics and outcome of ischemic stroke patients who are free of symptoms at 24 hours following thrombolysis.
    Strbian D; Sairanen T; Rantanen K; Piironen K; Atula S; Tatlisumak T; Soinne L;
    Cerebrovasc Dis; 2011; 31(1):37-42. PubMed ID: 20980752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.